Ogurtsova K, Guariguata L, Barengo NC, et al. IDF diabetes Atlas: global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2022;183: 109118.

Article  PubMed  Google Scholar 

U.K. Prospective Diabetes Study Group. U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes. 1995;44:1249–58.

Article  Google Scholar 

Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120–6.

Article  CAS  PubMed  Google Scholar 

Nishimura R, Nakagami T, Sone H, et al. Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: Subanalysis of a large-scale randomized controlled trial. Cardiovasc Diabetol. 2011;10:58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the funagata diabetes study. Diabetes Care. 1999;22:920–4.

Article  CAS  PubMed  Google Scholar 

Kadowaki S, Okamura T, Hozawa A, et al. Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. Nippon data 80. Diabetologia. 2008;51:575–82.

Article  CAS  PubMed  Google Scholar 

Turner RC, Millns H, Neil HAW, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). Br Med J. 1998;316:823–8.

Article  CAS  Google Scholar 

Sone H, Tanaka S, Tanaka S, et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the japan diabetes complications study (JDCS). J Clin Endocrinol Metab. 2011;96:3448–56.

Article  CAS  PubMed  Google Scholar 

Cholesterol Treatment Trialists’ Collaborators. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. The Lancet. 2008;371:117–25.

Article  Google Scholar 

Van Der Schouw YT, Van Der Graaf Y, Steyerberg EW, et al. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347:714–8.

Article  PubMed  Google Scholar 

Saely CH, Schindewolf M, Zanolin D, et al. Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: a prospective cohort study. Atherosclerosis. 2018;279:32–7.

Article  CAS  PubMed  Google Scholar 

Seferovic JP, Bentley-Lewis R, Claggett B, et al. Retinopathy, neuropathy, and subsequent cardiovascular events in patients with type 2 diabetes and acute coronary syndrome in the ELIXA: the importance of disease duration. J Diabetes Res. 2018;2018:1631263.

Article  PubMed  PubMed Central  Google Scholar 

Japan Atherosclerosis Society Group. Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022. Japan Atherosclerosis Society. 1st ed. Tokyo: Nishimura Co. Ltd; 2022.

Google Scholar 

Kinoshita M, Yokote K, Arai H, et al. Japan atherosclerosis society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb. 2018;25:846–984.

Article  PubMed  PubMed Central  Google Scholar 

Yasuda H, Sanada M, Kitada K, et al. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract. 2007;77:S178–83.

Article  CAS  PubMed  Google Scholar 

Wada T, Haneda M, Furuichi K, et al. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18:613–20.

Article  CAS  PubMed  Google Scholar 

Teramura S, Sankai T, Yamagishi K, et al. Changes in cardiovascular disease risk factors during menopausal transition in Japanese women: the circulatory risk in communities study (CIRCS). Menopause. 2023;30:88–94.

Article  PubMed  Google Scholar 

Spinler SA, Cziraky MJ, Willey V, et al. Frequency of attainment of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol goals in cardiovascular clinical practice (from the national cardiovascular data registry PINNACLE registry). Am J Cardiol. 2015;116:547–53.

Article  PubMed  Google Scholar 

Danchin N, Almahmeed W, Al-Rasadi K, et al. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: the international cholesterol management practice study (ICLPS). Eur J Prev Cardiol. 2018;25:1087–94.

Article  PubMed  PubMed Central  Google Scholar 

Bruckert E, Parhofer KG, Gonzalez-Juanatey JR, et al. Proportion of high-risk/very high-risk patients in europe with low-density lipoprotein cholesterol at target according to European guidelines: a systematic review. Adv Ther. 2020;37:2020–36.

Article  Google Scholar 

Ray KK, Molemans B, Marieke Schoonen W, et al. EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the davinci study. Eur J Prev Cardiol. 2021;28:1279–89.

Article  PubMed  Google Scholar 

Hermans MP, Castro Cabezas M, Strandberg T, et al. Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries. Curr Med Res Opin. 2010;26:445–54.

Article  CAS  PubMed  Google Scholar 

Mitani H, Suzuki K, Ako J, et al. Achievement rates for low-density lipoprotein cholesterol goals in patients at high risk of atherosclerotic cardiovascular disease in a real-world setting in Japan. J Atheroscler Thromb. 2023. https://doi.org/10.5551/jat.63940.

Article  PubMed  PubMed Central  Google Scholar 

Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685–96.

Article  CAS  PubMed  Google Scholar 

Hodkinson A, Tsimpida D, Kontopantelis E, et al. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. The BMJ. 2022;376: e067731.

Article  PubMed  PubMed Central  Google Scholar 

Seino H, Onishi Y, Eguchi K, Nishijima K, et al. Cardiovascular disease prevalence in adults with type 2 diabetes in Japan: results from the Japanese centers in the CAPTURE study. Diabetol Int. 2023;14:172–82.

Article  PubMed  PubMed Central  Google Scholar